Flannelly Barry P — SEC Form 4 filings
SEC reporting owner CIK 1615842. 19 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-01-19 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 8 filings — 65,540 shares, $4,274,333 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 19,147 shares @ $67.68 ($1,295,869) in INCYTE CORP, filed 2025-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INCYTE CORP (INCY) | EVP & General Manager US | 16 | — | 11 legs · 65,540 sh · $4,274,333 | 19 |
| Protara Therapeutics, Inc. (TARA) | Director | 3 | — | — | 3 |
Form 4 filings — Flannelly Barry P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | INCYTE CORP (INCY) | Sale (S): 1,340 @ $68.36 | EDGAR |
| 2025-07-16 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 922 @ $69.98 · Sale (S): 1,192 @ $69.86 · Tax withholding (F): 1,141 @ $68.25 | EDGAR |
| 2025-07-07 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 9,055 @ $68.17 · Sale (S): 10,903 @ $68.15 | EDGAR |
| 2025-06-13 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | INCYTE CORP (INCY) | Grant/award (A): 11,159 @ $0 · Grant/award (A): 14,976 @ $0 | EDGAR |
| 2025-03-18 | 4 | INCYTE CORP (INCY) | Sale (S): 461 @ $67.85 · Sale (S): 199 @ $67.88 · Sale (S): 19,147 @ $67.68 | EDGAR |
| 2025-01-22 | 4 | INCYTE CORP (INCY) | Grant/award (A): 20,144 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 3,158 @ $72.46 | EDGAR |
| 2024-12-11 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 1,510 @ $72.11 | EDGAR |
| 2024-11-08 | 4 | INCYTE CORP (INCY) | Option exercise (M): 1,424 @ $72.27 · Option exercise (M): 2,256 @ $68.62 · Sale (S): 1,424 @ $82 · Sale (S): 2,256 @ $78.21 · Option exercise (M): 1,424 (derivative) @ $0 · Option exercise (M): 2,256 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | INCYTE CORP (INCY) | Grant/award (A): 9,925 @ $0 · Tax withholding (F): 1,111 @ $64.25 · Sale (S): 1,306 @ $64.19 · Grant/award (A): 22,205 (derivative) @ $0 | EDGAR |
| 2024-07-11 | 4 | INCYTE CORP (INCY) | Sale (S): 8,148 @ $60 | EDGAR |
| 2024-07-03 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 7,695 @ $59.02 | EDGAR |
| 2024-06-14 | 4 | INCYTE CORP (INCY) | Sale (S): 19,164 @ $60 | EDGAR |
| 2024-06-10 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | INCYTE CORP (INCY) | Grant/award (A): 7,377 @ $0 | EDGAR |
| 2024-01-22 | 4 | INCYTE CORP (INCY) | Grant/award (A): 21,843 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 3,675 @ $61.48 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1615842 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →